Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.

MLA

Fagan, Anne M., et al. “Comparison of CSF Biomarkers in Down Syndrome and Autosomal Dominant Alzheimer’s Disease: A Cross-Sectional Study.” The Lancet. Neurology, vol. 20, no. 8, Aug. 2021, pp. 615–26. EBSCOhost, https://doi.org/10.1016/S1474-4422(21)00139-3.

APA

Fagan, A. M., Henson, R. L., Li, Y., Boerwinkle, A. H., Xiong, C., Bateman, R. J., Goate, A., Ances, B. M., Doran, E., Christian, B. T., Lai, F., Rosas, H. D., Schupf, N., Krinsky-McHale, S., Silverman, W., Lee, J. H., Klunk, W. E., Handen, B. L., Allegri, R. F., … Lott, I. T. (2021). Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet. Neurology, 20(8), 615–626. https://doi.org/10.1016/S1474-4422(21)00139-3

Chicago

Fagan, Anne M, Rachel L Henson, Yan Li, Anna H Boerwinkle, Chengjie Xiong, Randall J Bateman, Alison Goate, et al. 2021. “Comparison of CSF Biomarkers in Down Syndrome and Autosomal Dominant Alzheimer’s Disease: A Cross-Sectional Study.” The Lancet. Neurology 20 (8): 615–26. doi:10.1016/S1474-4422(21)00139-3.